Diabetic Ketoacidosis (DKA) is a life threatening metabolic complication of Type 2 Diabetic Mellitus that often presents with neurological symptoms. A state of severe insulin deficiency, either absolute or relative, resulting in hyperglycemia and ketonemia. Although possibly underappreciated, upto 10% of cases of intracerebral complications associated with an episode of DKA, and / or its treatment are due to hemorrhage or ischemic brain infarction. Thrombotic risk during DKA is elevated by abnormalities in coagulation factors, platelets activation, blood volume and flow , and vascular reactivity.

1. Diabetes Spectrum, January 2002 vol . 15 np. 1 28-36CMAJ. 2003 Apr 1: 168(7): 859-66
2. Strong K, Mathers C, Bonita R. Preventing Stroke : saving lives around the world . Lancet Neurol . 2007: 6: 182-187.
3. Curr Diabetes Rev. 2013 Jan 1 ; 9(1) : 25-63
4. Kissela BM , Khoury J , Kleindorfer D : Epidemiology of ischemic stroke in patients with diabetes:  Diabetic care . 2005;28(2): 355-359.
5. Endocrinol Metab Clin North Am. 2013 Dec ;42(4): 677-95 Diabetes Metab Syndr Obes. 2014 ;7: 255-264
6. Lin JJ,Lin KL, Wang HS .Occult infarct with acute hemorrhagic stroke in juvenile diabetic ketoacidosis
7. Distinctive characteristics and specific management of diabetic ketoacidosis in patients with acute MI, stroke and renal failure. In: Escher AP, Li A , editors.

Dr Tony Chandy Babu

Muthoot Hospitals Kozhencherry